Stephens Downgrades Halliburton (HAL) to Equal Weight

Go back to Stephens Downgrades Halliburton (HAL) to Equal Weight

Halliburton (HAL) PT Raised to $50 at JPMorgan

April 20, 2022 7:49 AM EDT

JPMorgan analyst Sean Meakim raised the price target on Halliburton (NYSE: HAL) to $50.00 (from $34.00) while maintaining a Overweight rating.... More

Halliburton (HAL) PT Raised to $47 at Stifel

April 20, 2022 7:33 AM EDT

Stifel analyst Stephen Gengaro raised the price target on Halliburton (NYSE: HAL) to $47.00 (from $42.00) while maintaining a Buy rating.... More

Halliburton (HAL) PT Raised to $49 at RBC Capital

April 20, 2022 7:13 AM EDT

RBC Capital analyst Keith Mackey raised the price target on Halliburton (NYSE: HAL) to $49.00 (from $45.00) while maintaining a Outperform rating.

... More

Halliburton (HAL) PT Raised to $48 at Susquehanna

April 20, 2022 6:48 AM EDT

Susquehanna analyst Charles Minervino raised the price target on Halliburton (NYSE: HAL) to $48.00 (from $45.00) while maintaining a Positive rating.

... More

Halliburton (HAL) PT Raised to $47 at BofA Securities

April 20, 2022 6:32 AM EDT

BofA Securities analyst Chase Mulvehill raised the price target on Halliburton (NYSE: HAL) to $47.00 (from $45.00) while maintaining a Buy rating.

... More

Halliburton (HAL) PT Raised to $48 at Citi

April 20, 2022 5:43 AM EDT

Citi analyst Scott Gruber raised the price target on Halliburton (NYSE: HAL) to $48.00 (from $44.00) while maintaining a Buy rating following results.

The analyst commented, "Expectations for HAL were high coming into the quarter and the company delivered a solid 2q guide. While the... More

Halliburton (HAL) PT Raised to $48 at CFRA

April 19, 2022 2:03 PM EDT

CFRA raised its price target on Halliburton (NYSE: HAL) to $48.00 (from $45.00) while maintaining a Buy rating.

... More

Pre-Open Stock Movers 04/19: Super Micro and American Campus Higher; NETGEAR and Stellantis Lower (more...)

April 19, 2022 9:24 AM EDT

Pre-Open Stock Movers:

Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) 332% HIGHER; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) agreed to acquire the company for $10.50 per share in cash.

System1, Inc. (NYSE: SST) 28% LOWER; registration statement on Form S-1, was declared effective.

Axsome Therapeutics (NASDAQ: AXSM) 27% HIGHER; received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with... More

Halliburton's profit jumps, outlook improves as drilling activity increases

April 19, 2022 6:48 AM EDT

By Liz Hampton and Rithika Krishna

(Reuters) -Oilfield services firm Halliburton Co on Tuesday posted an 85% rise in first-quarter adjusted profit and raised its forecast for customer spending in North America as a rally in oil and gas prices boosted demand.

Halliburton said it anticipates North American spending to grow by 35% this year due to stronger activity and inflation, revising higher an earlier estimate of a 25% increase.

Oil futures climbed to their highest in more than a decade during the quarter on market turmoil stemming from Russia's invasion of Ukraine. U.S. oil is around $105.34... More

Halliburton (HAL) Tops Q1 EPS by 1c

April 19, 2022 6:46 AM EDT

Halliburton (NYSE: HAL) reported Q1 EPS of $0.35, $0.01 better than the analyst estimate of $0.34. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.21 billion.

For earnings history and earnings-related data on Halliburton (HAL) click here.

... More